118 related articles for article (PubMed ID: 23748247)
61. Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking.
Lan P; Chen WN; Huang ZJ; Sun PH; Chen WM
J Mol Model; 2011 Jul; 17(7):1643-59. PubMed ID: 20978914
[TBL] [Abstract][Full Text] [Related]
62. Blocking HIV-1 entry by a gp120 surface binding inhibitor.
Tsou LK; Chen CH; Dutschman GE; Cheng YC; Hamilton AD
Bioorg Med Chem Lett; 2012 May; 22(9):3358-61. PubMed ID: 22487177
[TBL] [Abstract][Full Text] [Related]
63. Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1.
Zhao Y; Gu Q; Morris-Natschke SL; Chen CH; Lee KH
J Med Chem; 2016 Oct; 59(19):9262-9268. PubMed ID: 27676157
[TBL] [Abstract][Full Text] [Related]
64. Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors.
Andrianov AM; Nikolaev GI; Shuldov NA; Bosko IP; Anischenko AI; Tuzikov AV
J Biomol Struct Dyn; 2022 Oct; 40(16):7555-7573. PubMed ID: 33855929
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein.
Aggarwal M; Kaur R; Saha A; Mudgal R; Yadav R; Dash PK; Parida M; Kumar P; Tomar S
Antiviral Res; 2017 Oct; 146():102-111. PubMed ID: 28842264
[TBL] [Abstract][Full Text] [Related]
66. Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 Replication.
Schröder M; Kolodzik A; Windshügel B; Krepstakies M; Priyadarshini P; Hartjen P; van Lunzen J; Rarey M; Hauber J; Meier C
Arch Pharm (Weinheim); 2016 Feb; 349(2):91-103. PubMed ID: 26725082
[TBL] [Abstract][Full Text] [Related]
67. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element.
Tagat JR; McCombie SW; Steensma RW; Lin S; Nazareno DV; Baroudy B; Vantuno N; Xu S; Liu J
Bioorg Med Chem Lett; 2001 Aug; 11(16):2143-6. PubMed ID: 11514156
[TBL] [Abstract][Full Text] [Related]
68. Sulfotyrosine dipeptide: Synthesis and evaluation as HIV-entry inhibitor.
Ju T; Hu D; Xiang SH; Guo J
Bioorg Chem; 2016 Oct; 68():105-11. PubMed ID: 27475281
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists.
Emert-Sedlak LA; Loughran HM; Shi H; Kulp JL; Shu ST; Zhao J; Day BW; Wrobel JE; Reitz AB; Smithgall TE
Bioorg Med Chem Lett; 2016 Mar; 26(5):1480-1484. PubMed ID: 26852364
[TBL] [Abstract][Full Text] [Related]
70. Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitors.
Joao HC; De Vreese K; Pauwels R; De Clercq E; Henson GW; Bridger GJ
J Med Chem; 1995 Sep; 38(19):3865-73. PubMed ID: 7562918
[TBL] [Abstract][Full Text] [Related]
71. [Computer modeling of the promising inhibitors of the HIV-1 subtype A replication as a framework for the rational anti-aids drug design].
Andrianov AM; Anishchenko IV
Biomed Khim; 2011; 57(2):161-73. PubMed ID: 21870601
[TBL] [Abstract][Full Text] [Related]
72. Flexibility of small molecular CD4 mimics as HIV entry inhibitors.
Kobayakawa T; Ohashi N; Hirota Y; Takahashi K; Yamada Y; Narumi T; Yoshimura K; Matsushita S; Harada S; Tamamura H
Bioorg Med Chem; 2018 Nov; 26(21):5664-5671. PubMed ID: 30366786
[TBL] [Abstract][Full Text] [Related]
73. Research on anti-HIV-1 agents. Investigation on the CD4-Suradista binding mode through docking experiments.
Manetti F; Corelli F; Mongelli N; Borgia AL; Botta M
J Comput Aided Mol Des; 2000 May; 14(4):355-68. PubMed ID: 10815772
[TBL] [Abstract][Full Text] [Related]
74. Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques.
Oliviero G; Stornaiuolo M; D'Atri V; Nici F; Yousif AM; D'Errico S; Piccialli G; Mayol L; Novellino E; Marinelli L; Grieco P; Carotenuto A; Noppen S; Liekens S; Balzarini J; Borbone N
Anal Chem; 2016 Feb; 88(4):2327-34. PubMed ID: 26810800
[TBL] [Abstract][Full Text] [Related]
75. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
[TBL] [Abstract][Full Text] [Related]
76. Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir.
Meanwell NA; Krystal MR; Nowicka-Sans B; Langley DR; Conlon DA; Eastgate MD; Grasela DM; Timmins P; Wang T; Kadow JF
J Med Chem; 2018 Jan; 61(1):62-80. PubMed ID: 29271653
[TBL] [Abstract][Full Text] [Related]
77. Double Variational Binding--(SMILES) Conformational Analysis by Docking Mechanisms for Anti-HIV Pyrimidine Ligands.
Putz MV; Dudaș NA; Isvoran A
Int J Mol Sci; 2015 Aug; 16(8):19553-601. PubMed ID: 26295229
[TBL] [Abstract][Full Text] [Related]
78. In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.
Nowicka-Sans B; Gong YF; McAuliffe B; Dicker I; Ho HT; Zhou N; Eggers B; Lin PF; Ray N; Wind-Rotolo M; Zhu L; Majumdar A; Stock D; Lataillade M; Hanna GJ; Matiskella JD; Ueda Y; Wang T; Kadow JF; Meanwell NA; Krystal M
Antimicrob Agents Chemother; 2012 Jul; 56(7):3498-507. PubMed ID: 22547625
[TBL] [Abstract][Full Text] [Related]
79. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide.
Gomara MJ; Perez Y; Gomez-Gutierrez P; Herrera C; Ziprin P; Martinez JP; Meyerhans A; Perez JJ; Haro I
Sci Rep; 2020 Sep; 10(1):14430. PubMed ID: 32879375
[TBL] [Abstract][Full Text] [Related]
80. An insight into the binding mechanism of Viprinin and its morpholine and piperidine derivatives with HIV-1 Vpr: molecular dynamics simulation, principal component analysis and binding free energy calculation study.
Majumder S; Giri K
J Biomol Struct Dyn; 2022; 40(21):10918-10930. PubMed ID: 34296659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
